Home
>
National Drug Code (NDC)
>
Glycopyrrolate
Glycopyrrolate - 13107-014-11 - (Glycopyrrolate)
Drug Information of Glycopyrrolate
| Product NDC: | 13107-014 |
| Proprietary Name: | Glycopyrrolate |
| Non Proprietary Name: | Glycopyrrolate |
| Active Ingredient(s): | 1 mg/1 & nbsp; Glycopyrrolate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glycopyrrolate
| Product NDC: | 13107-014 |
| Labeler Name: | Aurolife Pharma, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202675 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130415 |
Package Information of Glycopyrrolate
| Package NDC: | 13107-014-11 |
| Package Description: | 10 TABLET in 1 BOTTLE (13107-014-11) |
NDC Information of Glycopyrrolate
| NDC Code | 13107-014-11 |
| Proprietary Name | Glycopyrrolate |
| Package Description | 10 TABLET in 1 BOTTLE (13107-014-11) |
| Product NDC | 13107-014 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glycopyrrolate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130415 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurolife Pharma, LLC |
| Substance Name | GLYCOPYRROLATE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
